$NUGS Overview - Updated November 3, 2026
New CEO: Richard C Hawkins
Backstory
- Came off EM August 27, 2026.
- Court proceedings have eliminated $14.6M in legacy liabilities including $1.395M in convertible debt notes.
- No convertible debt as at end-2026 Q2 [source: 2026 Q2 Report]
- 2,701.104 Common shares cancelled + all 12,457,086 Preferred C shares cancelled.
- Richard C Hawkins controls the company via one Series B super-voting share which has no conversion rights - so no potential dilution to common shareholders.
- 1st PR for new company on September 10, 2026 announced a non-binding Letter of Intent to Acquire Adport, a Mobile Out-of-Home Advertising Technology Business.
- 2nd PR for new company on November 3, 2026 announced termination of the non-binding Letter of Intent with Adport and the signing of a binding Letter of Intent with Scopien Technologies Inc. - see new relevant new section below.
- Liabilities reduced to $491,000 at September 30, 2026 [source: PR November 3, 2026]
Binding Letter Of Intent With Scopien Technologies Inc. [source: PR November 3, 2026]
- Signing of binding Letter of Intent announced November 3, 2026.
- Scopien will acquire voting control of $NUGS through the transfer of the Company’s Series B Super Voting Preferred Stock and contribute its operating business to the Company.
- Change of control due to take place by November 30, 2026.
- Scopien connects a company’s systems - including CRM, ERP, HR, payroll and helpdesk - into one operating platform and puts AI agents to work across it.
- Each customer runs its own instance in Scopien’s cloud and its own cloud on-premises - so data stays inside its walls.
- Scopien serves mid-market companies, enterprises and government, and plans to expand its sales and partner channels, product modules and engineering program.
- When the change of control closes, Scopien will appoint $NUGS’s officers and directors.
- Intends to change its name and trading symbol to reflect the Scopien business.
- Intends to complete PCAOB audits and file a registration statement with the SEC within 6 months after the change of control, with the goal of becoming a fully reporting company and pursuing a NASDAQ or NYSE listing.
About The CEO - Richard C Hawkins - Quotes In 1st PR [source: PRs September 10 and November 3, 2026]
- Mastermind behind $AGCI $AEFI $MIXE $AMFN and now $NUGS.
- "I am a staunch advocate for shareholders, and this Company [$NUGS] was brought back to a clean, current corporate footing for their benefit."
- "My thesis is straightforward: I take quality companies with disruptive technology public through shells that had a storied past and were then abandoned, restore them, and finance them responsibly, with the goal of becoming SEC reporting and uplisting to a major exchange."
- "For too long, development-stage companies were listed on an exchange prematurely and then diluted through toxic financing, with retail investors bearing the cost. I am endeavoring to do the inverse, starting on the OTC and methodically achieving the milestones that build value."
- "I want to make the OTC great again."
- "We rebuilt this company through the courts so shareholders would have something real to build on” - “Scopien is the kind of company we hoped to find.”
PRs - 2026
News - September 10, 2026. Cannabis Strategic Ventures, Inc. [OTC NUGS] Signs Letter of Intent to Acquire Adport, a Mobile Out-of-Home Advertising Technology Business
News - November 3, 2026. Cannabis Strategic Ventures, Inc. Signs Binding Letter of Intent with Scopien Technologies Inc.
Share Structure - As At November 3, 2026
No change to Outstanding Shares since coming off EM - no dilution
Authorized Shares: 988,000,000
Outstanding Shares: 402,294,983
- Restricted: 138,937,236
- Unrestricted: 263,357,747
Held At DTC: 258,250,949
Note 1: It is only the Held At DTC Shares count that is relevant to immediate trading provided this was updated at the same time as the Outstanding Shares count
Note 2: Extremely thin to the upside with only 258M shares Held At DTC for a stock in the .0047 > .1 range
Trading After Coming Off EM
On August 27, 2026 - 1st day off EM - opened .0090 - hod .0899 - closed .0162 on 25M traded.
While on EM, there were 176 beneficial shareholders [source: otcmarkets.com], so any pre-EM holders who wanted to exit had ample opportunity to do so and probably didn't even realize $NUGS was now a Richard C Hawkins ticker as a number posted they had no idea why it was moving.
A number of traders who bought on August 27, 2026 undoubtedly chased to get at least a starter position knowing that it was a Hawkins reverse merger ticker which hadn't yet PR'ed the takeover and debt elimination, let alone the new business
On August 28, 2026, a number of significant, top OTC traders caught up with developments and were scaling in all day - all of it at prices slightly cheaper than the close the previous day - mainly through large ask buying - especially when calling the bluff of MMs who walked down asks in attempts to get bids fills and who lost their shares on the ask almost immediately.
Since then trading was thin until the November 3, 2026 PR - mostly at prices under .01.
Catalysts Ahead
Expect to see:
- Update to the Company Profile / Business Description at otcmarkets.com - the cannabis business shown was abandoned under previous ownership [source: 2026 Q2 Report]
- Further PRs on a regular basis updating on the new business direction and action plan - leading to surges, excellent trading opportunities and large spreads when bidders get left behind:
-- Change of control.
-- Appointment of new officers and directors.
-- Name change and ticker change.
-- Completion of PCAOB audit.
-- Filing registration with SEC to become a fully reporting company.
-- Uplisted to NASDAQ or NYSE.
Website / Social Media
Website: www.scopien.com
X: https://x.com/ScopienOS
=================================================================================================
Not a financial advisor - just stating what I'm basing my trading decisions on.
I will be holding some $NUGS in my portfolio throughout 2026 and into future years for the long-term, trading some on surges from the bottom up too and reloading on any dips.
New CEO: Richard C Hawkins
Backstory
- Came off EM August 27, 2026.
- Court proceedings have eliminated $14.6M in legacy liabilities including $1.395M in convertible debt notes.
- No convertible debt as at end-2026 Q2 [source: 2026 Q2 Report]
- 2,701.104 Common shares cancelled + all 12,457,086 Preferred C shares cancelled.
- Richard C Hawkins controls the company via one Series B super-voting share which has no conversion rights - so no potential dilution to common shareholders.
- 1st PR for new company on September 10, 2026 announced a non-binding Letter of Intent to Acquire Adport, a Mobile Out-of-Home Advertising Technology Business.
- 2nd PR for new company on November 3, 2026 announced termination of the non-binding Letter of Intent with Adport and the signing of a binding Letter of Intent with Scopien Technologies Inc. - see new relevant new section below.
- Liabilities reduced to $491,000 at September 30, 2026 [source: PR November 3, 2026]
Binding Letter Of Intent With Scopien Technologies Inc. [source: PR November 3, 2026]
- Signing of binding Letter of Intent announced November 3, 2026.
- Scopien will acquire voting control of $NUGS through the transfer of the Company’s Series B Super Voting Preferred Stock and contribute its operating business to the Company.
- Change of control due to take place by November 30, 2026.
- Scopien connects a company’s systems - including CRM, ERP, HR, payroll and helpdesk - into one operating platform and puts AI agents to work across it.
- Each customer runs its own instance in Scopien’s cloud and its own cloud on-premises - so data stays inside its walls.
- Scopien serves mid-market companies, enterprises and government, and plans to expand its sales and partner channels, product modules and engineering program.
- When the change of control closes, Scopien will appoint $NUGS’s officers and directors.
- Intends to change its name and trading symbol to reflect the Scopien business.
- Intends to complete PCAOB audits and file a registration statement with the SEC within 6 months after the change of control, with the goal of becoming a fully reporting company and pursuing a NASDAQ or NYSE listing.
About The CEO - Richard C Hawkins - Quotes In 1st PR [source: PRs September 10 and November 3, 2026]
- Mastermind behind $AGCI $AEFI $MIXE $AMFN and now $NUGS.
- "I am a staunch advocate for shareholders, and this Company [$NUGS] was brought back to a clean, current corporate footing for their benefit."
- "My thesis is straightforward: I take quality companies with disruptive technology public through shells that had a storied past and were then abandoned, restore them, and finance them responsibly, with the goal of becoming SEC reporting and uplisting to a major exchange."
- "For too long, development-stage companies were listed on an exchange prematurely and then diluted through toxic financing, with retail investors bearing the cost. I am endeavoring to do the inverse, starting on the OTC and methodically achieving the milestones that build value."
- "I want to make the OTC great again."
- "We rebuilt this company through the courts so shareholders would have something real to build on” - “Scopien is the kind of company we hoped to find.”
PRs - 2026
News - September 10, 2026. Cannabis Strategic Ventures, Inc. [OTC NUGS] Signs Letter of Intent to Acquire Adport, a Mobile Out-of-Home Advertising Technology Business
News - November 3, 2026. Cannabis Strategic Ventures, Inc. Signs Binding Letter of Intent with Scopien Technologies Inc.
Share Structure - As At November 3, 2026
No change to Outstanding Shares since coming off EM - no dilution
Authorized Shares: 988,000,000
Outstanding Shares: 402,294,983
- Restricted: 138,937,236
- Unrestricted: 263,357,747
Held At DTC: 258,250,949
Note 1: It is only the Held At DTC Shares count that is relevant to immediate trading provided this was updated at the same time as the Outstanding Shares count
Note 2: Extremely thin to the upside with only 258M shares Held At DTC for a stock in the .0047 > .1 range
Trading After Coming Off EM
On August 27, 2026 - 1st day off EM - opened .0090 - hod .0899 - closed .0162 on 25M traded.
While on EM, there were 176 beneficial shareholders [source: otcmarkets.com], so any pre-EM holders who wanted to exit had ample opportunity to do so and probably didn't even realize $NUGS was now a Richard C Hawkins ticker as a number posted they had no idea why it was moving.
A number of traders who bought on August 27, 2026 undoubtedly chased to get at least a starter position knowing that it was a Hawkins reverse merger ticker which hadn't yet PR'ed the takeover and debt elimination, let alone the new business
On August 28, 2026, a number of significant, top OTC traders caught up with developments and were scaling in all day - all of it at prices slightly cheaper than the close the previous day - mainly through large ask buying - especially when calling the bluff of MMs who walked down asks in attempts to get bids fills and who lost their shares on the ask almost immediately.
Since then trading was thin until the November 3, 2026 PR - mostly at prices under .01.
Catalysts Ahead
Expect to see:
- Update to the Company Profile / Business Description at otcmarkets.com - the cannabis business shown was abandoned under previous ownership [source: 2026 Q2 Report]
- Further PRs on a regular basis updating on the new business direction and action plan - leading to surges, excellent trading opportunities and large spreads when bidders get left behind:
-- Change of control.
-- Appointment of new officers and directors.
-- Name change and ticker change.
-- Completion of PCAOB audit.
-- Filing registration with SEC to become a fully reporting company.
-- Uplisted to NASDAQ or NYSE.
Website / Social Media
Website: www.scopien.com
X: https://x.com/ScopienOS
=================================================================================================
Not a financial advisor - just stating what I'm basing my trading decisions on.
I will be holding some $NUGS in my portfolio throughout 2026 and into future years for the long-term, trading some on surges from the bottom up too and reloading on any dips.
Cannabis Strategic Ventures, Inc (NUGS) Stock Research Links
"Per Ardua Ad Astra" - "Through Adversity To The Stars"
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.
